Mosseri Marlio Charles

10% OwnerNuvectis Pharma, Inc. (NVCT) · full profile →Form 4 · filed Jul 1, 2026
Net Buying
Open-Market Buys
$916K
Open-Market Sells
$0
Net Open-Market Flow
$916K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 30, 2026Buy(P)50K$18.32$916K3.2M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-079793) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.